Free Trial

Sharps Technology Q4 2022 Earnings Report

Sharps Technology logo
$0.36 -0.16 (-31.45%)
As of 02/21/2025 04:00 PM Eastern

Sharps Technology EPS Results

Actual EPS
-$1.76
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Sharps Technology Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sharps Technology Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Sharps Technology Earnings Headlines

Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.
See More Sharps Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sharps Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sharps Technology and other key companies, straight to your email.

About Sharps Technology

Sharps Technology (NASDAQ:STSS), a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

View Sharps Technology Profile

More Earnings Resources from MarketBeat